Ignite Creation Date:
2024-05-05 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 9:41 AM
Study NCT ID:
NCT00591851
Status:
COMPLETED
Last Update Posted:
2023-09-25
First Post:
2007-12-26
Brief Title:
Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide AC Followed By Paclitaxel With Trastuzumab in HER2 NEU-Amplified Breast Cancer Feasibility
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Study Overview
Official Title:
Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide AC Followed By Paclitaxel With Trastuzumab in HER2 NEU-Amplified Breast Cancer Feasibility
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
HER-2neu breast cancer is a more aggressive form of breast cancer HER-2neu is a protein that is overproduced by your tumor It makes your cancer more aggressive Standard treatments for this type of cancer will help some people but there is a moderate to high chance that your cancer may come back
The purpose of this study is to see if a new regimen will be effective in preventing cancer from coming back This is a phase II trial In this trial patient get a drug regimen that has been tested in small groups of people to see what dose is safe Researchers now wish to see how effective the drug is for HER-2neu breast cancer The objective includes looking at short-term side effects and risks of the drug All of the drugs on this regimen can affect the heart which can be a serious side effect The drugs affect on heart function is a primary focus
The purpose of this study is to see if a new regimen will be effective in preventing cancer from coming back This is a phase II trial In this trial patient get a drug regimen that has been tested in small groups of people to see what dose is safe Researchers now wish to see how effective the drug is for HER-2neu breast cancer The objective includes looking at short-term side effects and risks of the drug All of the drugs on this regimen can affect the heart which can be a serious side effect The drugs affect on heart function is a primary focus
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None